JP2010530903A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530903A5
JP2010530903A5 JP2010513493A JP2010513493A JP2010530903A5 JP 2010530903 A5 JP2010530903 A5 JP 2010530903A5 JP 2010513493 A JP2010513493 A JP 2010513493A JP 2010513493 A JP2010513493 A JP 2010513493A JP 2010530903 A5 JP2010530903 A5 JP 2010530903A5
Authority
JP
Japan
Prior art keywords
connexin
seq
pharmaceutical composition
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010513493A
Other languages
English (en)
Japanese (ja)
Other versions
JP5552048B2 (ja
JP2010530903A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/067944 external-priority patent/WO2008157840A2/en
Publication of JP2010530903A publication Critical patent/JP2010530903A/ja
Publication of JP2010530903A5 publication Critical patent/JP2010530903A5/ja
Application granted granted Critical
Publication of JP5552048B2 publication Critical patent/JP5552048B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010513493A 2007-06-21 2008-06-23 加齢性黄斑変性を治療するためのアルファコネキシンｃ末端（ａｃｔ）ペプチド Expired - Fee Related JP5552048B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94549307P 2007-06-21 2007-06-21
US60/945,493 2007-06-21
PCT/US2008/067944 WO2008157840A2 (en) 2007-06-21 2008-06-23 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration

Publications (3)

Publication Number Publication Date
JP2010530903A JP2010530903A (ja) 2010-09-16
JP2010530903A5 true JP2010530903A5 (enExample) 2011-08-04
JP5552048B2 JP5552048B2 (ja) 2014-07-16

Family

ID=40156983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010513493A Expired - Fee Related JP5552048B2 (ja) 2007-06-21 2008-06-23 加齢性黄斑変性を治療するためのアルファコネキシンｃ末端（ａｃｔ）ペプチド

Country Status (5)

Country Link
US (2) US20110130345A1 (enExample)
EP (1) EP2166845B1 (enExample)
JP (1) JP5552048B2 (enExample)
DK (1) DK2166845T3 (enExample)
WO (1) WO2008157840A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827480B1 (en) 2004-12-21 2016-11-09 MUSC Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
MX351881B (es) 2012-03-01 2017-11-01 Firststring Res Inc Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act).
WO2013163423A1 (en) * 2012-04-25 2013-10-31 Musc Foundation For Research Development Compositions and methods for wound healing and tissue repair
US10981961B2 (en) * 2013-03-11 2021-04-20 University Of Florida Research Foundation, Incorporated Delivery of card protein as therapy for occular inflammation
US11053291B2 (en) 2014-02-19 2021-07-06 University Of Florida Research Foundation, Incorporated Delivery of Nrf2 as therapy for protection against reactive oxygen species
EP4050020A1 (en) 2014-03-11 2022-08-31 University of Florida Research Foundation, Inc. Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
JP7185655B2 (ja) * 2014-08-22 2022-12-07 オークランド ユニサービシーズ リミティド チャネル調節剤
ES2804039A1 (es) * 2019-07-30 2021-02-02 Fund Profesor Novoa Santos Fragmentos peptidicos de cx43 para su uso como agentes senoliticos
US12138293B2 (en) 2020-10-22 2024-11-12 Xequel Bio, Inc. Peptide formulations and ophthalmic uses thereof
CA3252591A1 (en) * 2022-05-13 2023-11-16 Character Biosciences, Inc. THERAPEUTIC LIPID COMPOSITIONS AND TREATMENT METHODS FOR AGE-RELATED MACULAR DEGENERATION
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601438A (enExample) 1968-10-17 1970-08-24
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
FR2739621B1 (fr) * 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
US7098190B1 (en) * 1999-01-27 2006-08-29 Coda Therapeutics Ltd. Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) * 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US7364750B2 (en) * 2001-04-30 2008-04-29 The University Of British Columbia Autogene nucleic acids encoding a secretable RNA polymerase
US6867283B2 (en) * 2001-05-16 2005-03-15 Technion Research & Development Foundation Ltd. Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
US20050053918A1 (en) * 2001-05-16 2005-03-10 Technion Research & Development Foundation Ltd. Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
JP2003238441A (ja) * 2002-02-08 2003-08-27 英行 ▲高▼野 血管新生抑制剤
WO2003096981A2 (en) * 2002-05-15 2003-11-27 Seul, Kyung, Hwan Method of modulating angiogenesis
WO2004073616A2 (en) * 2003-02-14 2004-09-02 Human Matrix Sciences Llc Elastin digest compositions and methods utilizing same
CN1922320B (zh) * 2003-12-03 2013-04-24 科达治疗（新西兰）有限公司 靶向连接蛋白的反义化合物及其使用方法
EP1827480B1 (en) * 2004-12-21 2016-11-09 MUSC Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
CN101573131B (zh) * 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用

Similar Documents

Publication Publication Date Title
Betzel et al. Three‐dimensional structure of proteinase K at 0.15‐nm resolution
RU2011139724A (ru) Композиции и способы, используемые для ускорения заживления ран и регенерации тканей
CA2989778C (en) Method of modifying peptide compositions
JP2010508022A5 (enExample)
NZ603732A (en) Cell-penetrating peptides and uses therof
US20060222657A1 (en) Polypeptide transduction and fusogenic peptides
JP2015504052A5 (enExample)
ES2637277T3 (es) Nuevas moléculas inhibidoras de JNK
CO6190536A2 (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores
JP2018530315A5 (enExample)
JP2004532033A5 (enExample)
JP2012522501A5 (enExample)
JP2010068806A5 (enExample)
JP2010534477A5 (enExample)
JP2015524403A5 (enExample)
JP2009525055A5 (enExample)
ES2321058T7 (es) Purificación de proteínas recombinantes fusionadas con epítopos múltiples
CN116096736A (zh) 新型冠状病毒rbd融合蛋白
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
JP2025509645A5 (enExample)
JP2008522954A5 (enExample)
TN2009000442A1 (en) Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
JP2026507112A (ja) ペプチドの産生及び精製のための方法及び組成物
Langedijk et al. New transport peptides broaden the horizon of applications for peptidic pharmaceuticals
CN106755042B (zh) 一种基于组合自剪切与蛋白支架的生物活性小肽制备方法